04/11/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/11/2020. This three-page fact sheet informs healthcare personnel of the significant known and potential risks and benefits of the emergency use of decontaminated, compatible N95 respirators during the COVID-19 pandemic. These compatible N95 respirators have been decontaminated using one of three Advanced Sterilization Products STERRAD Sterilization Systems, using the STERRAD Sterilization Cycles for N95 respirator decontamination: STERRAD 100S Cycle, STERRADNX Standard Cycle, or STERRAD100NX Express Cycle. (PDF)
04/10/2020 12:00 AM EDT
Source: Occupational Safety and Health Administration [U.S. Department of Labor] (OSHA). Published: 4/10/2020. This memorandum provides interim guidance to Compliance Safety and Health Officers (CSHOs) for enforcing the requirements of 29 CFR Part 1904 with respect to the recording of occupational illnesses, specifically cases of coronavirus disease 2019 (COVID-19). Under OSHA’s recordkeeping requirements, COVID-19 is a recordable illness, and employers are responsible for recording cases of COVID-19 under certain circumstances. (Text)
04/10/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/10/2020. This web page provides guidance for the management of public health workers engaged in public health activities that require face-to-face interaction with clients in clinic and field settings. These non-COVID-19 activities would include prevention and control programs for TB, STDs, HIV, and other infectious disease activities that would require outbreak or contact investigation, home visits, or partner services, and non-infectious disease-specific programs, e.g., syringe services programs, opioid response, or occupational health activities. (Text)
04/10/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/10/2020. This 10-page guidance communicates the Food and Drug Administration (FDA)'s temporary policy during the COVID-19 public health emergency related to personal protective equipment (PPE) use during human drug compounding, at state-licensed pharmacies or federal facilities that are not registered with FDA as outsourcing facilities (referred to collectively in this guidance as compounders). (PDF)
04/10/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/10/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the iAMP COVID-19 Detection Kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 10, 2020. The iAMP COVID-19 Detection Kit is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
04/10/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/10/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CytoSorb device for the reduction of pro-inflammatory cytokine levels, which received an Emergency Use Authorization from the Food and Drug Administration on April 10, 2020. The CytoSorb device is authorized for emergency use to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. (PDF)
04/10/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 4/10/2020. This one-hour webinar provides tips and best practices for caring for pediatric patients with COVID-19. Topics include National and Atlanta Experience; Critical Care Patient Zero; and Nursing and Operations Perspective. (Video or Multimedia)
04/09/2020 12:00 AM EDT
Source: National Institutes of Health (NIH). Published: 4/9/2020. COVID-19 open-access data and computational resources are being provided by federal agencies, including the National Institutes of Health (NIH); public consortia; and private entities. These resources are freely available to researchers, and this web page will be updated as more information becomes available. (Text)
04/09/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/9/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Spectra Optia Apheresis System with the Depuro D2000 Adsorption Cartridge for the reduction of pro-inflammatory cytokine levels, which received an Emergency Use Authorization from the Food and Drug Administration on April 9, 2020. The Spectra Optia Apheresis System with the Depuro D2000 Adsorption Cartridge is authorized for emergency use to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. (PDF)
04/09/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/9/2020. This three-page fact sheet informs healthcare personnel of the significant known and potential risks and benefits of the emergency use of decontaminated, compatible N95 respirators during the COVID-19 pandemic. These compatible N95 respirators have been decontaminated using the STERIS N95 Respirator Decontamination Cycle (Non-Lumen Cycle) in STERIS V-PRO 1 Plus, V-PRO maX, and V-PRO maX2 Sterilizers. (PDF)
04/09/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/9/2020. The U.S. Food and Drug Administration (FDA) has issued this six-page Emergency Use Authorization (EUA) in response to concerns relating to insufficient supply and availability of face shields for use by healthcare personnel as personal protective equipment (PPE) in healthcare settings in accordance with Centers for Disease Control and Prevention recommendations to cover the front and sides of the face and provide barrier protection during the coronavirus disease 2019 (COVID-19) pandemic. (PDF)
04/09/2020 12:00 AM EDT
Source: American Public Health Association (APHA). Published: 4/9/2020. This one-hour, 30-minute webinar is part of a COVID-19 Conversations series, co-sponsored with the National Academy of Medicine. The presenters detail emerging evidence on COVID-19 spread and treatment, examine some of the newest data available to understand how long the virus remains active on surfaces or in the air, and discuss the latest news about a promising treatment that's being studied for COVID-19: the use of convalescent plasma. (Video or Multimedia)
04/09/2020 12:00 AM EDT
Source: American Society of Nephrology (ASN). Published: 4/9/2020. This one-hour webinar addresses the care of home dialysis patients during the COVID-19 pandemic. It includes a report from the front lines, infection prevention and control considerations in the home, and advocacy updates related to care of patients on home dialysis. (Video or Multimedia)
04/08/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 4/8/2020. The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of Health and Human Services (HHS) to limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines. This five-page report reviews the structure of the PREP Act and the HHS Declaration to explain the scope of this liability immunity as it applies to COVID-19 countermeasures. (PDF)
04/08/2020 12:00 AM EDT
Source: Stanford University. Published: 4/8/2020. This one-page document authorizes the emergency use of the Stanford SARS-CoV-2 PCR Assay, which is eligible for authorization under the March 31, 2020, Emergency Use Authorization (EUA) for Molecular-based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2 (Molecular LDT COVID-19 Authorized Test). (PDF)
04/08/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Health [U.S. Department of Health and Human Services] (HHS OASH). Published: 4/8/2020. This one-page guidance authorizes, under the Public Readiness and Emergency Preparedness Act (PREP Act), licensed pharmacists to order and administer COVID-19 tests, including serology tests, that the Food and Drug Administration (FDA) has authorized. (PDF)
04/08/2020 12:00 AM EDT
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 4/8/2020. This two-page document provides an initial estimate of the incremental need for medical personal protective equipment (PPE) of various kinds (gloves, isolation gowns, medical-grade masks, and N95 or similar ventilators) above normal baseline utilization for a single 100-day COVID-19 wave. (PDF)
04/08/2020 12:00 AM EDT
Source: Johns Hopkins University. Published: 4/8/2020. This 45-minute webinar, part of the COVID-19 and Humanitarian Settings series, features panelists who discuss various lessons emerging from past global outbreaks of infectious disease through multiple perspectives and disciplines. From severe acute respiratory syndrome (SARS) in 2005, to H1N1 in 2009, to the recent Ebola outbreak in West Africa, each major outbreak has marked a milestone in the history of infectious diseases. They discuss what information has surfaced from these challenges to inform efforts to strengthen governance and response in today’s COVID pandemic. (Video or Multimedia)
04/08/2020 12:00 AM EDT
Source: American Hospital Association (AHA). Published: 4/8/2020. This one-page document provides information about the Battelle Critical Care Decontamination System (CCDS) and how it could help organizations access additional quantities of N95 and equivalent respirators during the COVID-19 pandemic. (PDF)
04/08/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 4/8/2020. This 55-minute webinar discusses requirements and engineering considerations when transforming a normal/positive room into a negative air room to provide care for COVID-19 patients. Topics include Types of Spaces Needed to Provide the Continuum of Care; Bellevue Hospital COVID-19 Facility/Engineering Response; and Conversions at Nebraska Medicine. (Video or Multimedia)
04/08/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 4/8/2020. This 51-minute COVID-19 webinar provides an overview of respiratory protection and guidance surrounding supply shortages. It also provides information on infection prevention measures, strategies for optimizing the supply of N95 respirators, and a broad overview of the use of elastomeric respirators in healthcare. (Video or Multimedia)
04/07/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 4/7/2020. This interim guidance outlines goals and strategies suggested for U.S. ambulatory care settings in response to community spread of coronavirus disease-2019 (COVID-19). It reflects the need to minimize disease transmission to patients, healthcare personnel, and others; identify persons with presumptive COVID-19 disease and implement a triage procedure to assign appropriate levels of care; reduce negative impacts on emergency department and hospital bed capacity; and maximize the efficiency of personal protective equipment (PPE) utilization across the community health system while protecting healthcare personnel. (Text)
04/07/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/7/2020. The World Health Organization has listed this diagnostic test for emergency use during the COVID-19 pandemic, detailed in this 18-page document. The move should help increase access to quality-assured, accurate tests for the disease. It also means that the tests can now be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. (PDF)
04/07/2020 12:00 AM EDT
Source: Translators without Borders (TWB). Published: 4/7/2020. Translators without Borders (TWB) has identified key terminology that people use to talk about COVID-19, as well as commonly-used technical terms, and used this to develop a multilingual, plain-language glossary that can support public information efforts. This can also be used as a progressive web app. If you add the web app to your home screen, you will also be able to use it offline (not currently supported on Apple devices). (Text)
04/07/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 4/7/2020. This five-page document provides recommendations on the management of dead bodies in the context of the novel coronavirus (COVID-19) in healthcare facilities. (PDF)
04/06/2020 12:00 AM EDT
Source: Johns Hopkins University. Published: 4/6/2020. This one-hour, 35-minute webinar provides an overview of the latest global and evidence-based recommendations related to infant and young child feeding (IYCF) and COVID-19. It includes suggestions and reflections around communication about breastfeeding with healthcare providers and caregivers, as well as suggestions for IYCF programming adaptation in the context of COVID-19. (Video or Multimedia)
04/03/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/3/2020. The World Health Organization has listed this diagnostic test for emergency use during the COVID-19 pandemic, detailed in this 31-page document. The move should help increase access to quality-assured, accurate tests for the disease. It also means that the tests can now be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. (PDF)
04/03/2020 12:00 AM EDT
Source: National Volunteer Fire Council (NVFC). Published: 4/3/2020. This 56-minute webinar discusses how the coronavirus disease 2019 (COVID-19) creates uncertainty and changes in lifestyle that can have an emotional and mental health impact, especially for firefighters, EMS providers, and rescue workers. (Video or Multimedia)
04/02/2020 12:00 AM EDT
Source: National Library of Medicine [National Institutes of Health] (NLM). Published: 4/2/2020. This resource is a series of 33 questions to ask about COVID-19 in a community survey. Categories include epidemiology, community interventions, and at-risk populations. (Text)
04/02/2020 12:00 AM EDT
Source: Henry J. Kaiser Family Foundation. Published: 4/2/2020. This web page details the results of the latest Kaiser Family Foundation Health Tracking poll, conducted March 25-30, 2020, which found that as many cities and states were issuing public health guidance requiring social distancing or shelter-in-place measures, seven in 10 Americans (72 percent) said their lives have been disrupted “a lot” or “some” by the coronavirus (COVID-19) outbreak. The vast majority of the public say U.S. policy should be prioritizing the slowing down of the spread of the coronavirus rather than the U.S. economy. (Text)
04/02/2020 12:00 AM EDT
Source: University of California, San Francisco (UCSF). Published: 4/2/2020. This questionnaire was developed by expert opinion. It will be used in two studies: the Study of Muscle Mobility and Aging (SOMMA), a study that is currently enrolling men and women age 70 and older to determine the biologic role of muscle in development of mobility disability, and the Osteoporotic Fractures in Men (MrOS Study), an ongoing multicenter cohort study of healthy aging of older men, with a particular focus on osteoporosis. MrOS men were initially enrolled in 2000-2002 and are all now in their mid-80s or older. In each study, organizers hope to administer the questionnaire two or three times over the coming months, along with select other repeated data from the cohorts (e.g., fall incidence, mobility function, activity level). (Text)
04/02/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 4/2/2020. This three-page report provides an overview of how personal protective equipment (PPE) such as gowns and masks for healthcare personnel, and respiratory devices, including ventilators, are regulated. It summarizes the Food and Drug Administration (FDA)’s response to mitigate reported PPE and ventilator shortages related to COVID-19. (PDF)
04/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 4/1/2020. This two-page document is designed to collect key information on COVID-19 case patients and persons under investigation, including demographic, clinical, and epidemiologic characteristics; exposure and contact history; and course of clinical illness and care received. (PDF)
04/01/2020 12:00 AM EDT
Source: American College of Emergency Physicians (ACEP). Published: 4/2020. This resource is a compilation of what is known now on the evaluation and treatment of COVID-19. It is a living document that will be updated as new information, guidance, and best practices evolve. This field guide aims to provide the information emergency physicians need to assess the available resources in their community and determine their local applications. (Text)
04/01/2020 12:00 AM EDT
Source: American Association of Blood Banks (AABB). Published: 4/2020. This website is a resource to educate interested donors, the healthcare community, and the public on the rapidly evolving therapy of COVID-19 convalescent plasma. It provides information to connect people who have recovered from COVID-19 to American Association of Blood Banks-accredited blood centers so that they can potentially donate convalescent plasma to help improve the status of critically ill patients with COVID-19. (Text)
04/01/2020 12:00 AM EDT
Source: Dialogue4Health. Published: 4/1/2020. Presenters in this one-hour, 30-minute webinar discuss pending federal legislation, states that have adopted laws regarding paid leave, and businesses that are expanding these benefits during the COVID-19 pandemic. They focus on the potential short-term uses of the recently approved supplemental budget to assist individuals without paid leave when confined to their homes. (Video or Multimedia)
04/01/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 4/2020. This 12-page report summarizes a workshop held on November 18, 2019, to examine the future of Army combat trauma care and emerging medical advancements that could improve soldier survivability in high-intensity conflicts in 2035. Workshop participants explored and discussed how bioengineering can return soldiers to the fight more quickly; areas of Army tactical combat care that can be improved now; and future related threats, risks, and status of preparedness. (Text)
03/31/2020 12:00 AM EDT
Source: Patient-Centered Outcomes Research Institute (PCORI). Published: 3/31/2020. This web page provides links to recordings and reports from a webinar series for hospitals and health systems across the country, which are confronting enormous challenges with capacity and patient flow during the COVID-19 pandemic. Past topics include How We Are Managing Incident Command, and Dealing with the Emergency Department Amid COVID-19. New webinars will be added as they take place. (Video or Multimedia)
03/30/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 3/30/2020. The Centers for Medicare and Medicaid Services (CMS) is providing additional guidance in this 11-page memorandum, updated on March 30, 2020, to dialysis facilities to help them focus their infection control and prevention practices to prevent the transmission of COVID-19 (coronavirus). It also provides answers to frequently asked questions about COVID-19 and dialysis facilities. (PDF)
03/30/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 3/30/2020. This eight-page memorandum responds to questions and provides important guidance for outpatient settings other than hospital outpatient departments, specifically Ambulatory Surgical Centers (ASCs), Community Mental Health Centers (CMHCs), Comprehensive Outpatient Rehabilitation Facilities (CORFs), Outpatient Physical Therapy or Speech Pathology Services (OPTs), Rural Health Clinics (RHCs), and Federally Qualified Health Centers (FQHCs), in addressing the COVID-19 outbreak and minimizing transmission to other individuals. (PDF)
03/30/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 3/30/2020. This 10-page provides additional guidance to Intermediate Care Facilities for Individuals with Intellectual Disabilities (ICF/IIDs) and Psychiatric Residential Treatment Facilities (PRTFs) to help control and prevent the spread of the virus SARS-CoV-2 and the disease it causes, COVID-19. (PDF)
03/30/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 3/30/2020. This 10-page memorandum, updated on March 30, 2020, responds to questions and provides important guidance for hospitals, psychiatric hospitals, and critical access hospitals (CAHs) in addressing the COVID-19 outbreak and minimizing transmission to other individuals. It addresses FAQs related to optimizing patient placement, with the goal of addressing the needs of the individual patient while protecting other patients and healthcare workers. (PDF)
03/30/2020 12:00 AM EDT
Source: Centers for Medicare & Medicaid Services (CMS). Published: 3/30/2020. This 17-page memorandum, updated on March 30, 2020, conveys information in response to inquiries from hospitals and critical access hospitals (CAHs) concerning implications of COVID-19 (coronavirus disease) for their compliance with the Emergency Medical Treatment and Labor Act (EMTALA). This guidance applies to both Medicare and Medicaid providers. Every hospital or CAH with a dedicated emergency department is required to conduct an appropriate medical screening examination of all individuals who come to the emergency department, including individuals who are suspected of having COVID-19. (PDF)
03/27/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 3/27/2020. This Topic Collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) focuses on plans, tools, templates, and other immediately implementable resources to help with COVID-19 preparedness, response, recovery, and mitigation efforts, focusing on workforce resilience, protection, and sustainability. (Text)
03/27/2020 12:00 AM EDT
Source: National Volunteer Fire Council (NVFC). Published: 3/27/2020. This one-hour webinar discusses how firefighters, EMS providers, and rescue workers may be feeling the impact especially hard as they navigate the new realities of responding and maintaining operations during the COVID-19 pandemic. It details strategies that responders can use to manage stress and anxiety, and to be there for each other during these uncertain times. (Video or Multimedia)
03/26/2020 12:00 AM EDT
Source: Children's Hospital Association. Published: 3/26/2020. This one-hour webinar, presented with the Centers for Disease Control and Prevention (CDC), describes the current epidemiology of COVID-19, reviews how outpatient hemodialysis facilities should prepare for patients with COVID-19, and reviews other CDC resources for COVID-19. (Video or Multimedia)
03/25/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 3/25/2020. In response to the novel coronavirus (COVID-19) outbreak in the United States, certain regulatory flexibilities for healthcare entities under Section 1135 of the Social Security Act have been provided. This three-page report summarizes Section 1135 and recent legislative and administrative developments relating to this authority. (PDF)
03/24/2020 12:00 AM EDT
Source: Montreal Behavioural Medicine Centre (MBMC). Published: 3/24/2020. This 11-page survey is for a study to explore the global awareness, attitudes, and adoption of recommended (and in some cases mandated) preventive measures and behaviors to slow the spread of the COVID-19 virus. The survey information will be provided to health authorities so that they can adapt the dissemination and implementation of future prevention measures to optimize public health interventions in an effort to reduce the global burden of COVID-19. (Text)
03/18/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 3/18/2020. This six-page report reviews several intellectual property (IP) rights provisions under current law that the federal government could use to try to ensure that COVID-19 countermeasures are accessible and affordable. (PDF)
03/01/2020 12:00 AM EST
Source: C4D Network (Community for Development). Published: 3/2020. This 22-page resource mapping contains signposting and direct links to a range of COVID-19 resource sites and content online. It includes information about the main sources for trustworthy information about the pandemic; sites for e-learning; organizations providing COVID-19 communication response guidance and tools; and sites providing downloadable materials such as fact sheets and posters, and access to material such as videos and audio. (PDF)
03/01/2020 12:00 AM EST
Source: C4D Network (Community for Development). Published: 3/2020. This 17-page guide seeks to address questions about how to face local communication challenges presented by the COVID-19 pandemic, and how communicators can respond effectively to the situation through supporting communities to cope and to protect themselves. It aims to provide insights for a wide range of local communicators on the community level. It covers the need for knowing and communicating the COVID-19 facts, understanding the pandemic's timeline and accompanying communication phases, and accessing resources and materials. (PDF)
No hay comentarios:
Publicar un comentario